Danielle Duffy

2.0k total citations
42 papers, 1.2k citations indexed

About

Danielle Duffy is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Danielle Duffy has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Surgery, 26 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Danielle Duffy's work include Lipoproteins and Cardiovascular Health (29 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (23 papers) and Cancer, Lipids, and Metabolism (7 papers). Danielle Duffy is often cited by papers focused on Lipoproteins and Cardiovascular Health (29 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (23 papers) and Cancer, Lipids, and Metabolism (7 papers). Danielle Duffy collaborates with scholars based in United States, Australia and Switzerland. Danielle Duffy's co-authors include Daniel J. Rader, LeAnne T. Bloedon, Rajesh Movva, Richard L. Dunbar, Mohamad Navab, Alan M. Fogelman, R. P. Norris, Megan L. Wolfe, Jesse Chittams and Frederick F. Samaha and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Journal of the American College of Cardiology.

In The Last Decade

Danielle Duffy

41 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Danielle Duffy United States	17	587	465	326	250	213	42	1.2k
Meliana Riwanto Switzerland	12	394 0.7×	382 0.8×	452 1.4×	320 1.3×	204 1.0×	17	1.2k
Tiziana Sampietro Italy	18	594 1.0×	356 0.8×	195 0.6×	156 0.6×	299 1.4×	75	1.1k
Richard L. Dunbar United States	18	664 1.1×	587 1.3×	308 0.9×	253 1.0×	513 2.4×	52	1.4k
Moira A. Clay Australia	14	592 1.0×	554 1.2×	283 0.9×	211 0.8×	180 0.8×	19	1.1k
Blake J. Cochran Australia	20	319 0.5×	261 0.6×	329 1.0×	188 0.8×	158 0.7×	51	972
Eric T. Alexander United States	18	692 1.2×	443 1.0×	626 1.9×	240 1.0×	144 0.7×	27	1.4k
Muhammad Yasin United States	5	1.1k 1.9×	783 1.7×	241 0.7×	326 1.3×	392 1.8×	13	1.7k
Sara Simonelli Italy	17	515 0.9×	423 0.9×	200 0.6×	184 0.7×	231 1.1×	28	884
Takeshi Kujiraoka Japan	20	506 0.9×	355 0.8×	231 0.7×	185 0.7×	155 0.7×	26	885
Yumiko Nakagawa-Toyama Japan	16	493 0.8×	218 0.5×	288 0.9×	147 0.6×	180 0.8×	24	919

Countries citing papers authored by Danielle Duffy

Since Specialization

Citations

This map shows the geographic impact of Danielle Duffy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Duffy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Duffy more than expected).

Fields of papers citing papers by Danielle Duffy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle Duffy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Duffy. The network helps show where Danielle Duffy may publish in the future.

Co-authorship network of co-authors of Danielle Duffy

This figure shows the co-authorship network connecting the top 25 collaborators of Danielle Duffy. A scholar is included among the top collaborators of Danielle Duffy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danielle Duffy. Danielle Duffy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Didichenko, Svetlana A., Elena Velkoska, Alexei Navdaev, et al.. (2023). CSL112 Infusion Rapidly Increases APOA1 Exchange Rate via Specific Serum Amyloid-Poor HDL Subpopulations When Administered to Patients Post–Myocardial Infarction. Arteriosclerosis Thrombosis and Vascular Biology. 43(6). 855–869. 9 indexed citations

Korjian, Serge, Gerald Chi, Arzu Kalaycı, et al.. (2023). Biological basis and proposed mechanism of action of CSL112 (apolipoprotein A-I [human]) for prevention of major adverse cardiovascular events in patients with myocardial infarction. European Heart Journal - Cardiovascular Pharmacotherapy. 9(4). 387–398. 15 indexed citations

Kalaycı, Arzu, C. Michael Gibson, Paul M. Ridker, et al.. (2022). ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future. Current Atherosclerosis Reports. 24(7). 585–597. 22 indexed citations

Zheng, Bo, Shinya Goto, Regina Clementi, et al.. (2022). Effect of CSL112 (apolipoprotein A‐I [human]) on cholesterol efflux capacity in Japanese subjects: Findings from a phase I study and a cross‐study comparison. Clinical and Translational Science. 15(10). 2331–2341. 5 indexed citations

Tortorici, Michael A., et al.. (2021). CSL112 (APOLIPOPROTEIN A-I [HUMAN]) SIMILARLY ENHANCES CHOLESTEROL EFFLUX CAPACITY IN JAPANESE AND CAUCASIAN SUBJECTS: FINDINGS FROM A PHASE 1 STUDY. Journal of the American College of Cardiology. 77(18). 131–131. 2 indexed citations

Lee, Jane, Gerald Chi, Clara Fitzgerald, et al.. (2021). ASSOCIATION OF CHOLESTEROL EFFLUX CAPACITY WITH ADVERSE CARDIOVASCULAR OUTCOMES - A META-ANALYSIS. Journal of the American College of Cardiology. 77(18). 1486–1486. 1 indexed citations

Lee, Jane, Gerald Chi, Clara Fitzgerald, et al.. (2021). Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis. Frontiers in Cardiovascular Medicine. 8. 774418–774418. 45 indexed citations

Gibson, C. Michael, Mathieu Kernéis, Megan K. Yee, et al.. (2018). The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarction. American Heart Journal. 208. 81–90. 28 indexed citations

Gille, Andreas, Samuel D. Wright, Michael A. Tortorici, et al.. (2017). Abstract 16500: CSL112 Restores Cholesterol Efflux in Patients Immediately After Acute Myocardial Infarction. Circulation. 3 indexed citations

10.

Valentino, Michael, et al.. (2016). Impact of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines on the prescription of high-intensity statins in patients hospitalized for acute coronary syndrome or stroke. American Heart Journal. 181. 130–136. 15 indexed citations

11.

Eldredge-Hindy, Harriet, Danielle Duffy, Kosj Yamoah, et al.. (2015). Modeled risk of ischemic heart disease following left breast irradiation with deep inspiration breath hold. Practical Radiation Oncology. 5(3). 162–168. 14 indexed citations

12.

Kelly, Erik, et al.. (2015). Targeting Lipoprotein (a): an Evolving Therapeutic Landscape. Current Atherosclerosis Reports. 17(5). 502–502. 9 indexed citations

13.

Duffy, Danielle, et al.. (2014). 2013 ACC/AHA cholesterol treatment guideline: Paradigm shifts in managing atherosclerotic cardiovascular disease risk. Trends in Cardiovascular Medicine. 25(4). 340–347. 19 indexed citations

14.

Duffy, Danielle, et al.. (2014). PA32540 for the secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcers. Expert Review of Cardiovascular Therapy. 12(11). 1251–1260. 2 indexed citations

15.

Duffy, Danielle, et al.. (2014). Aspirin for Cardioprotection and Strategies to Improve Patient Adherence. Postgraduate Medicine. 126(1). 18–28. 15 indexed citations

16.

Duffy, Danielle, DaJuanicia N. Holmes, Matthew T. Roe, & Eric D. Peterson. (2012). The impact of high-density lipoprotein cholesterol levels on long-term outcomes after non–ST-elevation myocardial infarction. American Heart Journal. 163(4). 705–713. 16 indexed citations

17.

Gotter, Anthony L., Manjunath Nimmakayalu, G. Reza Jalali, et al.. (2007). A palindrome-driven complex rearrangement of 22q11.2 and 8q24.1 elucidated using novel technologies. Genome Research. 17(4). 470–481. 47 indexed citations

18.

Duffy, Danielle & Daniel J. Rader. (2007). Endocannabinoid Antagonism: Blocking the Excess in the Treatment of High-Risk Abdominal Obesity. Trends in Cardiovascular Medicine. 17(2). 35–43. 14 indexed citations

19.

Hill, Rosina, et al.. (2006). Chromosome aberrations in Chinese hamster and human cells: A comparison using compounds with various genotoxicity profiles. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 616(1-2). 103–118. 22 indexed citations

20.

Duffy, Danielle & Daniel J. Rader. (2005). Drugs in development: targeting high-density lipoprotein metabolism and reverse cholesterol transport. Current Opinion in Cardiology. 20(4). 301–306. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact